Literature DB >> 12355212

Overexpression of cyclin E protein is closely related to the mutator phenotype of colorectal carcinoma.

Thomas Sutter1, Temuujin Dansranjavin, Jan Lubinski, Tadeusz Debniak, Joannis Giannakudis, Cuong Hoang-Vu, Henning Dralle.   

Abstract

BACKGROUND AND AIMS: A subset of colorectal carcinomas are due to a deficiency in the DNA mismatch repair system. The molecular mechanisms of tumorigenesis in these tumors is not yet well understood. Deregulation of the cell cycle, specifically of the G(1) and S phases, is a hallmark of human cancers. Transition from the G(1) to the S phase is accelerated by increased cyclin E protein expression, and recent studies suggest that overexpression of cyclin E leads to chromosomal instability. The overexpression of cyclin E in a variety of human cancers, for example in colorectal, gastric, lung, breast, and kidney cancer, provides evidence that cyclin E plays a pivotal role in the cell cycle and replication. We examined whether the overexpression of cyclin E is related to the status of the mismatch repair system in colorectal carcinomas. PATIENTS AND METHODS: Frozen tumor samples and adjacent normal colon mucosa obtained from 100 patients were subjected to microsatellite analysis, RT-PCR, western blot analysis and immunohistochemistry.
RESULTS: High microsatellite instability was detected in 13 tumors, and in 10 of these (77%) cyclin E protein was overexpressed at least twofold compared to normal mucosa. In contrast, only 28 of the remaining 87 microsatellite stable tumors (32%) overexpressed cyclin E. Lower molecular weight cyclin E proteins were present in 7 of 87 microsatellite stable carcinoma (8%), compared to 7 cases exhibiting lower molecular weight isoforms of 13 MSI carcinoma (54%).
CONCLUSION: Increased cyclin E protein expression and the appearance of lower molecular weight cyclin E proteins were significantly associated with MSI in colorectal tumors. The data indicate that increased and/or aberrant expression of cyclin E protein might contribute to the mutator phenotype of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12355212     DOI: 10.1007/s00384-002-0390-y

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  8 in total

1.  Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells.

Authors:  Zheng Guo; Yuning Zhou; B Mark Evers; Qingding Wang
Journal:  Biochem Biophys Res Commun       Date:  2012-01-20       Impact factor: 3.575

2.  Approach to early-onset colorectal cancer: clinicopathological, familial, molecular and immunohistochemical characteristics.

Authors:  Jose Perea; Edurne Alvaro; Yolanda Rodríguez; Cristina Gravalos; Eva Sánchez-Tomé; Barbara Rivera; Francisco Colina; Pablo Carbonell; Rogelio González-Sarmiento; Manuel Hidalgo; Miguel Urioste
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

Review 3.  Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.

Authors:  Joseph A Caruso; Mylinh T Duong; Jason P W Carey; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2018-09-07       Impact factor: 12.701

4.  Expression of cyclin E in stage III colorectal carcinoma.

Authors:  Lea Rath-Wolfson; Michael Bergman; Yaacov Ori; Alex Goldman; Edward Ram; Rumelia Koren; Hertzel Salman
Journal:  Oncol Lett       Date:  2012-10-05       Impact factor: 2.967

5.  Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features.

Authors:  Elli E Ioachim; Konstantinos H Katsanos; Michael C Michael; Epameinondas V Tsianos; Niki J Agnantis
Journal:  Int J Colorectal Dis       Date:  2004-04-02       Impact factor: 2.571

6.  Analysis of cyclin E co-expression genes reveals nuclear transcription factor Y subunit alpha is an oncogene in gastric cancer.

Authors:  Liang-Yu Bie; Dan Li; Yu Mu; Sheng Wang; Bei-Bei Chen; Hui-Fang Lyu; Li-Li Han; Cai-Yun Nie; Chang-Cheng Yang; Lin Wang; Chuan-Chuan Ren; Wei-Jie Zhang; Ping Guo; Feng Shi; Qing-Xia Fan; Liu-Xing Wang; Xiao-Bing Chen; Su-Xia Luo
Journal:  Chronic Dis Transl Med       Date:  2018-10-23

7.  Low-molecular-weight cyclin E: the missing link between biology and clinical outcome.

Authors:  Said Akli; Khandan Keyomarsi
Journal:  Breast Cancer Res       Date:  2004-07-07       Impact factor: 6.466

Review 8.  Molecular crosstalk between cancer and neurodegenerative diseases.

Authors:  Jiyeon Seo; Mikyoung Park
Journal:  Cell Mol Life Sci       Date:  2019-12-28       Impact factor: 9.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.